CXCL9 and type 2 diabetes mellitus: In the case of MIG, MDMs derived from patients with T2D exhibited different secretion patterns depending on the virulence of the Mtb clinical isolates, that is, those strains with a higher virulence (phenotypes 1 and 2) provoked higher secretion compared to those with a lower virulence (phenotype 4) [Supplementary data (Fig. 4B)].